EXEL
Exelixis Inc.Stock · Health Care$52.20−$4.50 (-7.94%)as of market close, Aug 6, 2026
EXEL — Exelixis Inc. stock price, chart and key statistics
Key stats
Price data
- Price
- $52.20
- Change YTD
- +19.10%
- Market cap
- 12.9B
- Enterprise value
- 12.3B
- Shares outstanding
- 247.8M
- 52W low
- $33.76
- 52W high
- $57.57
- From 52W high
- -9.33%
- From 52W low
- +54.62%
- 52W range
- 77%
- Beta
- 0.41
Volume
- Rel volume
- 1.75×
- 30D volume
- 2.7M
- 30D $ vol
- 149.8M
Fundamentals
- Sales (ttm)
- 2.4B
- Sales/share
- $9.83
- EPS (ttm)
- $3.18
- FCF (ttm)
- 1.2B
- FCF/share
- $4.73
- Book value/share
- $7.44
- Net margin
- 35.33%
- ROE
- 46.68%
- ROA
- 34.50%
- Current ratio
- 3.46
Growth (CAGR, ttm) · 10Y
- Sales
- +42.28%
- Net income
- n/a
- FCF
- +34.47%
- Shares
- +0.73%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- n/a
- Sales/share
- +41.25%
- FCF/share
- +33.50%
- Book value/share
- n/a
- Price
- +16.67%
- Total return
- +16.67%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 16.4×
- P/OI (ttm)
- 13.3×
- Fwd P/E
- 14.0×
- P/S (ttm)
- 5.3×
- P/B (mrq)
- 7.0×
- P/FCF (ttm)
- 11.0×
- EV/EBITDA (fy)
- 12.3×
- EV/Sales (ttm)
- 5.0×
- FCF yield (ttm)
- 9.06%
- Buyback yield (realized, 1y)
- 7.98%
- Shareholder yield (realized, 1y)
- 7.98%
- Buyback yield (cash, ttm)
- 8.62%
- Shareholder yield (cash, ttm)
- 8.62%
Vs own 10Y history
- P/E
- 17th
- P/OI
- 8th
- P/S
- 48th
- P/B
- 79th
- P/FCF
- 4th
Bar = where today's multiple sits in EXEL's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return
1D
-7.94%
1W
-6.74%
1M
-6.97%
3M
+7.19%
YTD
+19.10%
1Y
+39.35%
5Y
+209.61%
Financial statements
Open full EXEL financials →Related Health Care
1MExelixis Inc. (EXEL) trades at $52.20 with a live price and an interactive chart covering 26+ years of daily price history, plus key valuation metrics. ChartRow also publishes EXEL's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full EXEL financial statements →
